Pharmaceutical proteins in plants. A strategic genetic engineering approach for the production of tuberculosis antigens (Articolo in rivista)

Type
Label
  • Pharmaceutical proteins in plants. A strategic genetic engineering approach for the production of tuberculosis antigens (Articolo in rivista) (literal)
Anno
  • 2008-01-01T00:00:00+01:00 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
  • 10.1196/annals.1428.089 (literal)
Alternative label
  • Frutos R., Denise H., Vivares C., Neuhaus J.M., Vitale A., Pedrazzini E., Ma J., Dix P., Gray J., Pezzotti M., Conrad U., Robinson D. (2008) (2008)
    Pharmaceutical proteins in plants. A strategic genetic engineering approach for the production of tuberculosis antigens
    in Annals of the New York Academy of Sciences
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Frutos R., Denise H., Vivares C., Neuhaus J.M., Vitale A., Pedrazzini E., Ma J., Dix P., Gray J., Pezzotti M., Conrad U., Robinson D. (2008) (literal)
Pagina inizio
  • 275 (literal)
Pagina fine
  • 280 (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#url
  • http://onlinelibrary.wiley.com/doi/10.1196/annals.1428.089/full (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
  • 1149 (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • RF,French Agricultural Research Center for International Development, Montpellier, France HD, CV, Université Blaise Pascal Clermont-Ferrand II, Aubière, France J-MN,Université de Neuchatel, Neuchatel, Switzerland SV, EP, Istituto di Biologia e di Biotecnologia Agraria, Milano, Italy JM, St. George's Hospital, London, UK PD, National University of Ireland, Maynooth, Ireland JG, University of Cambridge, Cambridge, United Kingdom MP, Universita di Verona, Verona, Italy UC, Universitat Gatersleben, Gatersleben, Germany DR, Universitat Heidelberg, Heidelberg, Germany (literal)
Titolo
  • Pharmaceutical proteins in plants. A strategic genetic engineering approach for the production of tuberculosis antigens (literal)
Abstract
  • Tuberculosis (TB) is a re-emerging disease that is considered a major human health priority aswell as an important disease of livestock. TB is also a zoonosis, and Mycobacterium tuberculosis and M. bovis, the human and bovine causative agents, respectively, are very closely related. Protection against TB is essentially achieved through vaccination with the Bacille Calmetle-Guerin (BCG) strain of M. bovis. Protection is, however, incomplete, and novel improved vaccines are currently under investigation. Production of protective antigens in transgenic plants, or \"pharming,\" is a promising emerging approach, and a zoonosis-like TB is a good model for investigating the potential of this approach. Pharma-Planta, a European Commission-funded project and consortium, was set up to address this topic, within which a component is aimed at assessing the production efficacy and stability of the TB antigens in different compartments of the plant cell. This article ismeant to introduce this promising approach for veterinary medicine by describing the ongoing project and its specific genetic engineering strategy. (literal)
Prodotto di
Autore CNR
Insieme di parole chiave

Incoming links:


Prodotto
Autore CNR di
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
Insieme di parole chiave di
data.CNR.it